BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Brief//FDA catalyst calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Brief — FDA catalyst calendar
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:event-146@catalystbrief.girapphe.com
DTSTAMP:20261118T181551Z
LAST-MODIFIED:20261118T181551Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:Readout: Novartis Pharmaceuticals — Placebo [Jan 2027]
DESCRIPTION:Phase 3 primary completion: Evaluation of Efficacy and Safety o
 f Early in Hospital Initiation of Inclisiran Treatment in Patients With Ac
 ute Coronary Syndromes.\nSource: https://clinicaltrials.gov/study/NCT07102
 628\nhttps://catalystbrief.girapphe.com/e/146?lang=en\nNot investment advi
 ce. Dates may change.
URL:https://catalystbrief.girapphe.com/e/146?lang=en
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
